Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 300-326-6 | CAS number: 93925-25-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Between 04 November 2011 and 05 December 2011 (experimental phase)
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Valid and conclusive guideline study under GLP
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2012
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Version / remarks:
- Commission Regulation (EC) number 440/2008
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- 1997
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- JAPAN: Guidelines for Screening Mutagenicity Testing Of Chemicals
- Version / remarks:
- (including METI, MHLW and MAFF guidances)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Department of Health of Government of the U.K., inspection 19-21 July 2011; no analysis carried out to determine the homogeneity, concentration or stability of the test item formulation
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Phosphonic acid, mixed C12-20-alkyl and C14-18-unsatd. alkyl derivs.
- EC Number:
- 300-326-6
- EC Name:
- Phosphonic acid, mixed C12-20-alkyl and C14-18-unsatd. alkyl derivs.
- Cas Number:
- 93925-25-8
- Molecular formula:
- Complex
- IUPAC Name:
- Phosphonic acid, mixed C12-20-alkyl and C14-18-unsatd. alkyl derivs.
- Test material form:
- liquid: viscous
- Details on test material:
- - Substance type: Organic
- Physical state: White liquid
- Analytical purity: Considered to be 100 % due to the UVCB character
- Lot/batch No.: 0100823714
- Expiration date of the lot/batch: 28 September 2012
- Storage condition of test material: Room temperature, in the dark
- Other: Date received at the test laboratory: 28 September 2011
Constituent 1
Method
- Target gene:
- Histidine for Salmonella typhimurium, Tryptophan for Escherichia coli
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Additional strain / cell type characteristics:
- other: Genotypes: TA1535 = his G 46, rfa-, uvr B-; TA1537 = his C 3076, rfa-, uvr B-; TA 98 = his D 3052, rfa-, uvr B-, R-factor; TA 100 = his G 46, rfa-, uvr B-, R-factor; WP2 = trp-, uvr A-
- Metabolic activation:
- with and without
- Metabolic activation system:
- Phenobarbitone and ß-Naphthoflavone induced rat liver, S9
- Test concentrations with justification for top dose:
- Preliminary Toxicity Test: 0, 0.15, 0.5, 1.5, 5, 15, 50, 150, 500, 1500 and 5000 µg/plate
Mutation Test - Experiments 1 and 2 (Range-finding Test and Main Test): 50, 150, 500, 1500 and 5000 µg/plate - Vehicle / solvent:
- - Vehicle/solvent used: Acetone
- Justification for choice of solvent/vehicle: The test item was immiscible in dimethyl sulphoxide (DMSO) at 50 mg/mL but was fully miscible in acetone at 100 mg/mL in solubility checks performed in house. Following solubility information provided by the Sponsor, sterile distilled water was not evaluated as a potential vehicle in this test system. Acetone was therefore selected as the vehicle.
Controlsopen allclose all
- Untreated negative controls:
- yes
- Remarks:
- Spontaneous mutation rates of all strains used
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Acetone
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- 4-Nitroquinoline-N-oxide (CAS 56-57-5) at 0.2 µg/plate for TA 98; 9-Aminoacridine (CAS 90-45-9) at 80 µg/plate for TA 1537; N-ethyl-N'-nitro-N-nitrosoguanidine (CAS 4245-77-6) at 2, 3 and 5 µg/plate for WP2, TA 100 and TA 1535, respectively
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 9-aminoacridine
- N-ethyl-N-nitro-N-nitrosoguanidine
- Remarks:
- Without metabolic activation (-S9)
- Untreated negative controls:
- yes
- Remarks:
- Spontaneous mutation rates of all strains used
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Acetone
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- Benzo(a)pyrene (CAS 50-32-8) at 5 µg/plate for TA98 or 2-Aminoanthracene (CAS 613-13-8) at 1, 2, 2 and 10 µg/plate for TA 100, TA 1535, TA 1537 and WP2, respectively
- Positive control substance:
- benzo(a)pyrene
- other: 2-Aminoanthracene
- Remarks:
- With metabolic activation (+S9)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: In agar (plate incorporation)
DURATION
- Preincubation period for bacterial strains: 10 h
- Exposure duration: 48 - 72 h
NUMBER OF REPLICATIONS: Triplicate plating
DETERMINATION OF CYTOTOXICITY
- Method: Plates were assessed for numbers of revertant colonies and examined for effects on the growth of the bacterial background lawn. - Evaluation criteria:
- ACCEPTANCE CRITERIA
The reverse mutation assay may be considered valid if the following criteria are met:
- All tester strain cultures exhibit a characteristic number of spontaneous revertants per plate in the vehicle and untreated controls.
- The appropriate characteristics for each tester strain have been confirmed, e.g. rfa cell-wall mutation and pKM101 plasmid R-factor etc.
- All tester strain cultures should be in the approximate range of 0.9 to 9 • 10^9 bacteria per mL.
- Each mean positive control value should be at least twice the respective vehicle control value for each strain, thus demonstrating both the intrinsic sensitivity of the tester strains to mutagenic exposure and the integrity of the S9-mix.
- There should be a minimum of four non-toxic test item dose levels.
- There should not be an excessive loss of plates due to contamination.
EVALUTION CRITERIA
There are several criteria for determining a positive result, such as a dose-related increase in revertant frequency over the dose range tested and/or a reproducible increase at one or more concentrations in at least one bacterial strain with or without metabolic activation. Biological relevance of the results will be considered first, statistical methods, as recommended by the UKEMS can also be used as an aid to evaluation, however, statistical significance will not be the only determining factor for a positive response. A test item will be considered non-mutagenic (negative) in the test system if the above criteria are not met. Although most experiments will give clear positive or negative results, in some instances the data generated will prohibit a definitive judgement about the test item activity. Results of this type will be reported as equivocal. - Statistics:
- Standard deviation and Dunnett's linear regression analysis
Results and discussion
Test results
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Remarks:
- Tested up to maximum recommended dose of 5000 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: There was no marked change in pH when the test item was dosed into media; pH 7.33 without test item, range from 9.77 to 2500 µg test item/mL was pH 7.29 to 7.32 with no visible trend, these data were taken from the MLA study of Flanders (2012, Harlan Report no. 41103491)
- Effects of osmolality: The osmolality did not increase by more than 50 mOsm when the test item was dosed into media; mOsm 383 without test item; range from 9.77 to 2500 µg test item/mL was 387 to 307 decreasing with increasing test item concentration, these data were taken from the MLA study of Flanders (2012, Harlan Report no. 41103491)
- Evaporation from medium: Unlikely due to the low vapour pressure of the test item (0.00043 Pa at 25 °C, Tremain & Atwal 2011, Harlan Report no. 41103264)
- Water solubility: The test item can be considered water insoluble (water solubility < 0.1 mg/L at 20 °C, Fox & White 2012, Harlan Report no. 41103263), therefore it was dissolved in acetone.
- Precipitation: A test item precipitate (globular in appearance) was noted under an inverted microscope at 1500 µg/plate and by eye at 5000 µg/plate, this observation did not prevent the scoring of revertant colonies.
RANGE-FINDING/SCREENING STUDIES:
Preliminary Toxicity Test: The test item was non-toxic to the strains of bacteria used (TA100 and WP2). The test item formulation and S9-mix used in this experiment were both shown to be sterile.
COMPARISON WITH HISTORICAL CONTROL DATA:
All master strains were found to be satisfactory when were checked for characteristics, viability and spontaneous reversion rate prior to use. The amino acid supplemented top agar and S9 mix used in both experiments was shown to be sterile. There was also no evidence of excessive contamination. The culture density for each bacterial strain used in each experiment was also checked and considered acceptable. All of the positive control chemicals used in the test induced marked increases in the frequency of revertant colonies thus confirming the activity of the S9-mix and the sensitivity of the bacterial strains. - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Preliminary Toxicity Test
The following table shows the colony counts and precipitation observations.
Table 1: Numbers of revertant colonies in the preliminary toxicity test and observation of precipitation
Strain |
With (+) or |
Dose [µg/plate] |
||||||||||
0 |
0.15 |
0.5 |
1.5 |
5 |
15 |
50 |
150 |
500 |
1500 |
5000 |
||
TA 100 |
- |
113 |
107 |
96 |
113 |
78 |
75 |
94 |
86 |
113 |
99 |
83P |
+ |
98 |
81 |
94 |
74 |
95 |
79 |
93 |
86 |
81 |
81 |
99P |
|
WP2 |
- |
25 |
24 |
26 |
22 |
20 |
24 |
22 |
19 |
21 |
21 |
22P |
+ |
39 |
25 |
40 |
26 |
28 |
38 |
22 |
37 |
35 |
33 |
33P |
P: Precipitate observed
Mutation Test
The results for the negative controls (spontaneous mutation rates) are presented below in Table 2 and were considered to be acceptable. These data are for concurrent untreated control plates performed on the same day as the Mutation Test.
Table 2: Spontaneous Mutation Rates (Concurrent Negative Controls)
Experiment |
Strain |
Number of revertants [colonies per plate] |
||||
Replicate |
Mean |
|||||
1 |
2 |
3 |
||||
Range-finding Test |
Base pair substitution type |
TA 100 |
75 |
73 |
79 |
76 |
TA 1535 |
14 |
13 |
9 |
12 |
||
WP2 |
20 |
19 |
13 |
17 |
||
Frameshift substitution type |
TA 98 |
30 |
22 |
22 |
25 |
|
TA 1537 |
14 |
10 |
13 |
12 |
||
Main Test |
Base pair substitution type |
TA 100 |
87 |
97 |
98 |
94 |
TA 1535 |
15 |
19 |
21 |
18 |
||
WP2 |
25 |
35 |
18 |
26 |
||
Frameshift substitution type |
TA 98 |
24 |
27 |
32 |
28 |
|
TA 1537 |
14 |
12 |
11 |
12 |
The mean number (from 3 replicates) of revertant colonies and the standard deviations, for the test item, positive and vehicle controls, both with and without metabolic activation, are presented in Table 3 below.
Table 3: Number of revertants in the treatments and the positive control and observation of precipitationExperiment |
Strain |
Mean Number of revertants± Standard Deviation |
||||||
Dose [µg/plate] |
Positive control (as indicated above) |
|||||||
0 (Negative control) |
50 |
150 |
500 |
1500 |
5000 |
|||
-S9 Range-finding Test |
TA 100 |
70±8.4 |
72±10.8 |
63±2.0 |
70±8.5 |
66±2.5 |
71P±11.0 |
539±40.0 |
TA 1535 |
16±1.5 |
11±0.6 |
15±3.1 |
16±1.5 |
9±1.2 |
12P±0.6 |
218±60.9 |
|
WP2 |
23±6.1 |
26±0.6 |
19±3.1 |
14±5.8 |
19±2.1 |
19P±4.7 |
960±31.5 |
|
TA 98 |
14±2.1 |
16±2.5 |
15±2.3 |
16±3.8 |
9±0.6 |
9P±1.0 |
120±21.7 |
|
TA 1537 |
14±2.6 |
13±4.4 |
10±4.2 |
9±3.2 |
6±1.5 |
6P±1.2 |
1014±144.4 |
|
+S9 Range-finding Test |
TA 100 |
76±10.5 |
78±8.1 |
80±1.0 |
73±3.2 |
80±3.5 |
70P±10.6 |
623±37.6 |
TA 1535 |
13±3.2 |
11±1.2 |
10±1.5 |
13±3.8 |
16±5.0 |
12P±1.7 |
394±43.7 |
|
WP2 |
28±3.2 |
28±3.5 |
21±4.0 |
30±4.0 |
25±4.5 |
32P±4.7 |
121±15.1 |
|
TA 98 |
14±4.7 |
11±0.6 |
11±1.7 |
12±2.1 |
11±1.2 |
13P±3.6 |
311±8.7 |
|
TA 1537 |
15±2.9 |
11±3.2 |
13±4.9 |
12±3.0 |
20±0.6 |
14P±1.5 |
335±25.1 |
|
-S9 Main Test |
TA 100 |
85±7.2 |
91±2.9 |
85±6.9 |
84±9.0 |
91±4.9 |
94±6.1 |
532±3.2 |
TA 1535 |
18±3.2 |
14±4.4 |
16±2.3 |
19±5.5 |
14±1.5 |
13±5.0 |
170±4.0 |
|
WP2 |
28±4.4 |
25±5.5 |
23±4.6 |
24±5.0 |
26±5.9 |
30±8.7 |
769±54.8 |
|
TA 98 |
26±6.1 |
33±5.0 |
31±7.2 |
22±6.8 |
19±5.5 |
9±2.3 |
127±20.6 |
|
TA 1537 |
9±3.5 |
10±3.6 |
6±1.2 |
6±1.7 |
6±0.6 |
5±1.2 |
1319±210.8 |
|
+S9 Main Test |
TA 100 |
91±10.1 |
84±3.5 |
90±12.9 |
77±13.1 |
75±9.2 |
76±14.5 |
1354±153.5 |
TA 1535 |
11±2.5 |
13±4.7 |
9±1.0 |
12±1.5 |
9±2.6 |
11±2.5 |
357±6.1 |
|
WP2 |
33±4.5 |
28±7.0 |
27±6.0 |
29±4.6 |
31±2.5 |
25±4.6 |
147±5.3 |
|
TA 98 |
13±4.4 |
13±5.0 |
10±1.7 |
12±3.8 |
10±2.6 |
11±2.6 |
286±1.0 |
|
TA 1537 |
11±4.6 |
9±1.5 |
12±3.5 |
7±2.6 |
7±2.5 |
12±1.7 |
295±1.7 |
P: Precipitate observed
A graphical presentation of the data is given in the illustration below.
The test item caused no visible reduction in the growth of the bacterial background lawn at any dose level and was, therefore, tested up to the maximum recommended dose level of 5000 µg/plate. A test item precipitate (globular in appearance) was noted under an inverted microscope at 1500 µg/plate and by eye at 5000 µg/plate, this observation did not prevent the scoring of revertant colonies. No significant increases in the frequency of revertant colonies were recorded for any of the bacterial strains, with any dose of the test item, either with or without metabolic activation in either the range-finding or main tests. All of the positive control chemicals used in the test induced marked increases in the frequency of revertant colonies thus confirming the activity of the S9-mix and the sensitivity of the bacterial strains.Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative (no gene mutagenic effect in bacteria with and without metabolic activation)
Non-mutagenic to bacteria (absence of reverse mutation) - Executive summary:
The genetic toxicity (in vitro) of the test item was investigated in a GLP-compliant study by testing for bacterial reverse mutation (Ames test) using the strains TA 1535, TA 1537, TA 98, TA 100 (Salmonella typhimurium) and WP2 (Escherichia coli) according to the EU B.13/14 (2008), OECD TG 471 (1997) and OPPTS 870.5100 (1998) protocols and compatible with the guidelines for bacterial mutagenicity testing published by the major Japanese Regulatory Authorities including METI, MHLW and MAFF. The experiment is deemed valid, conclusive and thus suitable for assessment without restrictions.
The five bacterial strains were treated with the test item, using the Ames plate incorporation method at five dose levels, in triplicate, both with and without the addition of a rat liver homogenate metabolising system (10 % liver S9 in standard co-factors). The dose range for the range-finding test was determined in a preliminary toxicity assay and was 50 to 5000 µg/plate. The experiment was repeated on a separate day using the same dose range as the range-finding test, fresh cultures of the bacterial strains and fresh test item formulations.
The vehicle (acetone) control plates gave counts of revertant colonies within the normal range. All of the positive control chemicals used in the test induced marked increases in the frequency of revertant colonies, both with or without metabolic activation. Thus, the sensitivity of the assay and the efficacy of the S9-mix were validated.
The test item caused no visible reduction in the growth of the bacterial background lawn at any dose level and was, therefore, tested up to the maximum recommended dose level of 5000 µg/plate. A test item precipitate (globular in appearance) was noted under an inverted microscope at 1500 µg/plate and by eye at 5000 µg/plate, this observation did not prevent the scoring of revertant colonies.
No significant increases in the frequency of revertant colonies were recorded for any of the bacterial strains, with any dose of the test item, either with or without metabolic activation in either the range-finding or main tests.
In conclusion the test item was found non-mutagenic (in vitro) to bacteria in that it did not cause reverse mutation under the conditions of this test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
